By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Cardium Therapeutics, Inc. 

3611 Valley Centre Drive
Suite 525
San Diego  California  92130  U.S.A.
Phone: 858-436-1000 Fax: 858-436-1001


Company News
Cardium Therapeutics, Inc. (CXM) Announces Review In Journal Of Cardiovascular Pharmacology Finds Gene Therapy For Subset Of Heart Disease Patients 'Highly Warranted' 8/13/2014 7:43:20 AM
Cardium Therapeutics, Inc. (CXM) Announces Positive Interim Phase 3 Clinical Data Showing Significant Efficacy Of Generx® Angiogenic Gene Therapy For Myocardial Ischemia Due To Coronary Artery Disease At The 2014 Biotechnology Industry Organization (BIO) International Convention 6/24/2014 10:11:37 AM
Cardium Therapeutics, Inc. (CXM) To Announce Interim Results Of Generx Angiogenic Gene Therapy Phase 3 Clinical Study At The 2014 Biotechnology Industry Organization (BIO) International Convention 6/12/2014 8:08:18 AM
Shanxi Taxus To Gain Control Of Cardium Therapeutics, Inc. (CXM) With $5 Million Investment 3/9/2014 8:06:12 PM
Cardium Therapeutics, Inc. (CXM) Announces Strategic Focus On Advanced Regenerative Therapeutics Based On Generx Clinical Findings 1/27/2014 9:17:07 AM
Cardium Therapeutics, Inc. (CXM) Reports On Third Quarter 2013 Financial Results And Recent Business Developments 11/19/2013 11:08:55 AM
Cardium Therapeutics, Inc. (CXM) Announces Publication on Use of Excellagen for Managing Chronic Pressure Ulcers in Elderly Patients 11/8/2013 10:09:30 AM
Cardium Therapeutics, Inc. (CXM) Provides Update on Exchange Listing 10/8/2013 8:51:56 AM
Unusual Trading Activity in Cardium Therapeutics, Inc. (CXM) Common Stock 9/30/2013 8:16:17 AM
Cardium Therapeutics, Inc. (CXM)'s LifeAgain Launches First Life Insurance Program Developed for Men With Active Localized Prostate Cancer 9/16/2013 10:34:44 AM